The multistep syntheses of the novel functionalized bis(pyrazol-1-yl)methane ligands, bis(5-diphenylphosphinopyrazol-1-yl)methane (bppzm) 1, bis(5-diphenylphosphinopyrazol-1-yl)trimethylsilylmethane (bppztm) 2 and bis(2-diphenylphosphinoimidazol-1-yl)methane (bpizm) 3, have been studied. The coordinative capacity of the bppzm ligand towards a variety of early and late metal fragments was evaluated and seven metallacycles were isolated. The complex [{NbCl3(dme)}n] (dme = 1,2-dimethoxyethane) reacted with an excess of bppzm to give the binuclear complex [{NbCl3(bppzm)}2] 4, and in the same way the reaction of the mononuclear species [NbCl3(dme)(RCCR′)] with 1 gave the appropriate [NbCl3(bppzm)(RCCR′)] complexes (R = R′ = Ph 5; R = R′ = SiMe3 6; R = Ph, R′ = Me 7; R = Ph, R′ = SiMe3 8). In all these niobium complexes, 1 behaves as an N,N chelate ligand. Compound 1 reacts with [MCl2(PhCN)2] (M = Pd, Pt) to yield the complexes [MCl2(bppzm)] (M = Pd 9, Pt 10), where a P,P chelate behaviour for 1 was observed. A dynamic conformation of the six- and eight-membered metallacycles formed in the complexes was observed and variable-temperature NMR studies were carried out. Finally, the molecular structure of complex 10 was determined crystallographically and a distorted square-planar geometry was found in which a proton (Hendo) of the bridging methylene is in close proximity to the metal centre in the boat–boat conformation of the metallacycle.
No takes yet. Share an insight, caveat, or question.
Antiñolo et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: